Adma biologics, inc. (ADMA)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
REVENUES:
Product revenue

10,164

12,001

7,186

6,525

3,492

4,020

4,194

4,620

4,006

-

4,693

3,363

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

230

-

-

-

-

-

-

-

Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

2,593

-

2,902

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,236

2,088

-

1,821

1,291

1,484

-

1,347

1,481

1,541

-

1,088

736

-

-

-

-

-

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35

35

58

31

18

18

18

18

18

18

18

18

6

0

-

0

-

-

-

-

-

-

-

-

License and other revenue

35

-

35

35

35

-

35

35

35

-

35

35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License and other revenue

-

-

-

-

-

-

-

-

-

-

-

-

35

-

35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

Other revenue

-

-

-

-

-

35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Revenues

10,199

12,037

7,222

6,560

3,528

4,056

4,230

4,656

4,042

12,002

4,729

3,399

2,628

3,327

2,937

2,271

2,123

2,512

1,852

1,309

1,503

1,488

1,365

1,500

1,560

424

1,107

743

792

523

360

230

4

761

0

0

0

-

-

Total Revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

792

-

360

-

-

-

-

-

-

-

-

OPERATING EXPENSES
Cost of product revenue (exclusive of amortization expense shown below)

16,829

11,691

7,916

10,491

9,405

11,142

9,164

9,645

12,242

-

11,291

4,334

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product revenue (exclusive of amortization expense shown below)

-

-

-

-

-

-

-

-

-

-

-

-

1,616

2,014

1,735

1,344

1,266

1,502

1,112

786

909

956

867

940

977

282

726

485

529

-

144

-

2

-

0

0

-

-

-

Cost of product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

141

-

-

-

-

-

-

-

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

0

0

-

-

-

Research and development

1,528

464

491

516

870

917

1,002

1,040

965

1,204

1,814

1,358

1,192

583

1,677

3,399

2,027

1,996

2,111

1,505

1,401

1,919

1,482

1,783

4,330

2,956

1,408

3,470

1,467

1,267

1,940

178

81

203

56

139

246

-

-

Loss on sale of research and development inventory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1,329

-605

-

-

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

-

-

-

3

3

Plasma center operating expenses

500

464

456

594

654

2,260

1,973

1,738

1,833

1,841

1,582

1,600

1,479

1,390

1,482

1,294

1,280

1,258

1,214

1,096

1,048

1,209

1,018

820

802

705

657

539

515

419

489

379

459

4

450

364

376

1

0

Amortization of intangible assets

178

211

211

211

211

211

211

211

211

887

273

73

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

7,932

7,032

7,197

6,086

5,595

6,073

5,670

5,438

5,321

5,843

4,195

4,435

4,277

3,283

1,779

1,724

1,707

1,884

2,078

1,437

1,345

1,111

1,035

1,542

1,134

998

845

1,090

1,431

696

1,034

736

674

499

261

314

356

-

-

TOTAL OPERATING EXPENSES

26,969

19,863

16,272

17,899

16,737

20,604

18,021

18,073

20,574

22,546

19,157

11,801

8,565

7,271

6,674

7,762

6,282

6,642

6,516

4,826

4,705

5,197

4,404

5,087

7,244

4,942

3,638

5,586

3,943

2,765

3,609

1,436

1,215

8

768

2,147

1,585

5

4

LOSS FROM OPERATIONS

-16,769

-7,826

-9,050

-11,338

-13,208

-16,547

-13,791

-13,417

-16,532

-10,543

-14,427

-8,401

-5,937

-3,944

-3,736

-5,490

-4,158

-4,130

-4,664

-3,516

-3,202

-3,708

-3,038

-3,587

-5,683

-4,518

-2,530

-4,843

-3,150

-2,240

-3,248

-1,206

-1,213

-121

-768

-2,147

-1,585

-

-

OTHER INCOME (EXPENSE):
Interest and other income

248

181

281

209

127

60

75

33

26

22

8

7

18

13

11

12

13

11

11

9

4

5

3

3

1

1

2

3

0

5

5

2

7

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

Interest expense

2,717

2,730

2,649

2,072

1,540

1,437

1,402

1,359

1,323

1,241

782

642

618

628

605

537

467

463

449

453

476

381

335

342

226

167

162

158

128

16

2

3

8

-

-

240

316

-

-

Change in fair value of stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

67

-30

-14

-34

5

-17

2

21

36

0

0

0

0

-

-

-

-

-

-

Loss on extinguishment of debt

0

0

0

0

-9,962

0

0

0

0

-

-

-

-

-

-

-

-

-

0

-719

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on transfer of plasma center assets

0

-

0

0

11,527

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense

-6

-

-20

-10

-11

-

-17

-4

6

-

0

0

0

-

0

4

-

-

0

0

-

-

-

-

-

-

0

82

-

-

0

0

-

-

-

-

-

-

-

Other expense

-

-

-

-

-

-112

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other (expense) income, net

-2,475

-2,734

-2,388

-1,873

140

-1,490

-1,344

-1,330

-1,289

-2,439

-774

-634

-599

-614

-594

-521

-453

-451

-438

-1,162

-403

-406

-346

-373

-219

-182

-157

-52

-91

-11

3

-0

-1

-

-212

-239

-315

-

-

LOSS BEFORE INCOME TAXES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,251

-3,245

-1,206

-1,214

-954

-981

-2,387

-1,901

-

-

State income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-617

0

0

0

-320

-

-

NET LOSS

-19,245

-10,561

-11,438

-13,211

-13,067

-18,037

-15,135

-14,747

-17,822

-12,982

-15,202

-9,036

-6,536

-4,559

-4,331

-6,012

-4,612

-4,582

-5,102

-4,679

-3,605

-3,563

-3,384

-3,961

-5,903

-4,701

-2,688

-4,895

-3,241

-2,251

-3,245

-1,206

-597

-8

-981

-2,387

-1,580

-5

-4

Weighted average number of common shares outstanding - basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,500

-

-

-

2,500

2,500

BASIC AND DILUTED LOSS PER COMMON SHARE

-0.26

-0.17

-0.19

-0.25

-0.28

-0.39

-0.33

-0.35

-0.39

-0.26

-0.59

-0.55

-0.51

-0.34

-0.34

-0.50

-0.43

-0.44

-0.48

-0.44

-0.37

-0.38

-0.36

-0.43

-0.64

-0.54

-0.46

-0.83

-0.55

-0.46

-0.55

-0.20

-0.18

0.00

-2.79

-6.79

-4.50

0.00

0.00

WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted

73,781

59,515

59,317

52,206

46,353

46,351

46,350

42,712

45,317

36,479

25,790

16,427

12,886

12,894

12,886

12,121

10,710

10,380

10,707

10,705

9,855

9,291

9,291

9,291

9,291

8,511

5,871

5,871

5,871

5,878

5,910

5,910

3,363

-

-

-

-

-

-

WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

351

351

351

-

-